Guo, A
Lu, P
Lee, J
Zhen, C
Chiosis, G
Wang, Y L
Article History
Received: 8 July 2016
Revised: 30 October 2016
Accepted: 31 October 2016
First Online: 23 January 2017
Competing interests
: Memorial Sloan-Kettering Cancer Center holds the intellectual rights to PU-H71 (GC). Samus Therapeutics, of which GC has partial ownership, has licensed PU-H71. The remaining authors declare no conflict of interest.